ESTROGEN RECEPTOR POSITIVE
Clinical trials for ESTROGEN RECEPTOR POSITIVE explained in plain language.
Never miss a new study
Get alerted when new ESTROGEN RECEPTOR POSITIVE trials appear
Sign up with your email to follow new studies for ESTROGEN RECEPTOR POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope: Pre-Surgery combo shrinks breast tumors
Disease control OngoingThis study tested whether giving chemotherapy (paclitaxel and cyclophosphamide) with or without the targeted drug trastuzumab before surgery helps shrink breast cancer tumors in 92 women with early-stage or locally advanced breast cancer. The goal was to see if the treatment redu…
Matched conditions: ESTROGEN RECEPTOR POSITIVE
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Could Pre-Surgery radiation shrink breast tumors and spare healthy tissue?
Disease control OngoingThis study tests whether giving radiation therapy before surgery can shrink tumors in people with hormone receptor-positive, HER2-negative breast cancer. The goal is to make the tumor smaller so less healthy tissue needs to be removed during surgery. The trial involves 25 adults …
Matched conditions: ESTROGEN RECEPTOR POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New imaging method could reveal how well hormone therapy works in breast cancer
Knowledge-focused OngoingThis study tests a special PET scan called FES PET/CT to see how breast cancer tumors respond to hormone therapy. It involves 2 adults with estrogen receptor-positive breast cancer that is new, has come back, or spread. The scan measures changes in hormone receptor levels before,…
Matched conditions: ESTROGEN RECEPTOR POSITIVE
Phase: PHASE2 • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated May 17, 2026 08:12 UTC